BridgeMD
New treatment option for Multiple Sclerosis
Official title Reducing Fatigue in People With Multiple Sclerosis by Treatment With TENS
ClinicalTrials.gov ID: NCT05500963
What this study is testing
- What it's testing
- The objective of the randomized, sham-controlled trial will be to evaluate the effectiveness of treatment with transcutaneous electrical nerve stimulation (TENS) at reducing the level of fatigue experienced by people with MS.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Men and women18-65 yrs
- Able to read, understand, and speak English to ensure safe participation in the project
- Clinical diagnosis of relapsing-remitting MS
- Self-reported difficulty with walking
- On stable doses of Ampyra, provigil, or other symptomatic-treating medications
You likely can't join if
- Vision or hearing problems that have not been corrected
- Problems with sensations to temperature, pressure, or pain
- Any arm or leg problems that would influence the ability to hold a weight
- Surgery to the arms or legs that continues to bother the participant
- Metal implants
- Medical diagnosis or condition that is considered to be an absolute or relative contraindication to participating in exercise training, such as major...
See the full eligibility criteria
- Men and women18-65 yrs
- Able to read, understand, and speak English to ensure safe participation in the project
- Clinical diagnosis of relapsing-remitting MS
- Self-reported difficulty with walking
- On stable doses of Ampyra, provigil, or other symptomatic-treating medications
- No relapse or systemic steroids within the last 30 days
- Able to arrange transportation to the Boulder campus
- Vision or hearing problems that have not been corrected
- Problems with sensations to temperature, pressure, or pain
- Any arm or leg problems that would influence the ability to hold a weight
- Surgery to the arms or legs that continues to bother the participant
- Metal implants
- Medical diagnosis or condition that is considered to be an absolute or relative contraindication to participating in exercise training, such as major renal, pulmonary, hepatic, cardiac, gastrointestinal, HIV, cancer...
- History of head injury or stroke
- Taking antidepressants, anticholinergics, stimulants, sedatives, cannabis, illicit drugs or medications to treat herpes or neurologic pain.
- Diagnosis of diabetes mellitus
- Poorly controlled hypertension
- History of seizure disorders
- ≥2 alcoholic drinks/day, or present history (last 6 months) of drug abuse
- Spasticity that requires the individual to change intended activities more often than once a week
- Skin diseases or sensation problems in the legs or hands that influences some activities more often than once a week
- Inability to attend exercise sessions 3 days per week for 6 weeks
The study team makes the final eligibility decision.
Where it's taking place
- Boulder, Colorado, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boulder, Colorado, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.